کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2478073 1113331 2013 11 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Médicaments innovants et prix conditionnels : le contrat de performance, à l'opposé du partage de risques
موضوعات مرتبط
علوم پزشکی و سلامت داروسازی، سم شناسی و علوم دارویی اکتشاف دارویی
پیش نمایش صفحه اول مقاله
Médicaments innovants et prix conditionnels : le contrat de performance, à l'opposé du partage de risques
چکیده انگلیسی
Across global borders and throughout the various sectors of health care, the search for viable methods to pay for value has intensified. Driven by soaring costs and constrained budgets, public and private payers are seeking innovative ways to incentivize providers and product manufacturers to focus on effective outcomes for patients according to key performance indexes. Conditional pricing and performance-based payment for innovative medicines could facilitate access to quasi-monopsonic french market, in a context of financial crisis, loss of reciprocal confidence, and growing aversion for therapeutic and economical uncertainty. However, we consider these new methods of payment should not be termed “risk-sharing agreements”, a misleading term despite its common use today. They also should not impact the national list prices of medicines, that is a decisive tool for stabilizing international trade.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Annales Pharmaceutiques Françaises - Volume 71, Issue 5, September 2013, Pages 291-301
نویسندگان
,